MBX Biosciences Inc. Common Stock

MBX | NASDAQ

$61.75

+$0.81 (+1.33%)

Sep 22, 2026, 1:15 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
PE Ratio	-13.25	-9.96	-23.19	-28.84
PEG Ratio	-0.46	-0.12	-0.95	n/a
PS Ratio	n/a	n/a	n/a	n/a
PB Ratio	3.12	2.39	-10.40	-17.68
P/FCF Ratio	-14.06	-11.08	-23.46	-31.97
P/OCF Ratio	-14.40	-11.25	-23.56	-32.58
OCF/S Ratio	n/a	n/a	n/a	n/a
Debt / Equity Ratio	0	0	0	-0.01
Quick Ratio	24.62	24.19	21.26	12.89
Current Ratio	24.62	24.19	21.26	12.89
Asset Turnover	n/a	n/a	n/a	n/a
Interest Coverage	n/a	n/a	n/a	-67.28
Return on Equity	-23.56%	-24.05%	44.93%	61.34%
Return on Assets	-22.58%	-23.06%	-38.68%	-57.96%
Return on Invested Capital	-26.51%	-26.47%	-43.92%	-60.19%
Dividend Yield	n/a	n/a	n/a	n/a
Payout Ratio	n/a	n/a	n/a	n/a
FCF Payout Ratio	n/a	n/a	n/a	n/a
Gross Profit Margin	n/a	n/a	n/a	n/a
Net Profit Margin	n/a	n/a	n/a	n/a
Pretax Profit Margin	n/a	n/a	n/a	n/a
Operating Profit Margin	n/a	n/a	n/a	n/a
FCF Margin	n/a	n/a	n/a	n/a
EBITDA Margin	n/a	n/a	n/a	n/a